MatthewAlfredGubensMDMS
Oncology • San Francisco, CAHematologic Oncology, Thoracic Cancer
Assistant Clinical Professor, Thoracic Oncology
Dr. Gubens is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
505 Parnassus Ave
San Francisco, CA 94143Phone+1 415-353-2742- Is this information wrong?
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Medical Oncology, 2008 - 2011
University of California (San Francisco)Residency, Internal Medicine, 2005 - 2008
Stanford University School of MedicineClass of 2005
Certifications & Licensure
CA State Medical License 2007 - 2024- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Stereotactic Radiosurgery or Other Local Ablation Then Erlotinib in Epidermal Growth Factor Receptor (EGFR) Start of enrollment: 2012 Dec 11
- LDK378 Versus Chemotherapy in ALK Rearranged (ALK Positive) Patients Previously Treated With Chemotherapy (Platinum Doublet) and Crizotinib Start of enrollment: 2013 Jun 28
- Pembrolizumab With or Without Chemotherapy Before Surgery in Treating Patients With Stage I-IIIA Non-Small Cell Lung Cancer Start of enrollment: 2020 May 29
Publications & Presentations
PubMed
- Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis.Pooja Middha, Rohit Thummalapalli, Michael J Betti, Lydia Yao, Zoe Quandt, Karmugi Balaratnam, Cosmin A Bejan, Eduardo Cardenas, Christina J Falcon, David M Faleck, , ...> ;Nature Communications. 2024 Mar 26
- 1 citationsSurvival outcomes for lung neuroendocrine tumors in California differ by sociodemographic factors.Claire K Mulvey, Alan Paciorek, Farhana Moon, Paige Steiding, Brandon Shih, Matthew A Gubens, Li Zhang, Emily K Bergsland, Iona Cheng> ;Endocrine-Related Cancer. 2024 Jan 1
- Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis.Pooja Middha, Rohit Thummalapalli, Michael J Betti, Lydia Yao, Zoe Quandt, Karmugi Balaratnam, Cosmin A Bejan, Eduardo Cardenas, Christina J Falcon, David M Faleck, , ...> ;Medrxiv. 2023 Sep 13
- Join now to see all
Press Mentions
Conference Coverage: NCCN Clinical UpdatesApril 16th, 2019
ASCO 2017 – Lung Cancer – A Practice Change for ALK+ Lung Cancer Patients, Alecensa for First Line TreatmentAugust 9th, 2017- ASCO 2017 – Lung Cancer – Sequencing Treatments for ALK+ Lung Cancer in a Crowded Field – Is There a Place for Lorlatinib?August 9th, 2017
- Join now to see all
Professional Memberships
- Member
- Member
Hospital Affiliations
UCSF Medical CenterSan Francisco, California
Zuckerberg San Francisco General Hospital and Trauma CenterSan Francisco, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
